Global Implantable Collamer Lens Market
Medical Equipment

Global Implantable Collamer Lens Market Forecast 2026–2035: Long-Term Growth Insights

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

Across 2026–2030, what is the expected market valuation path of the Implantable Collamer Lens Market?

The implantable collamer lens market has demonstrated significant expansion in recent years. This market is projected to expand from $20.77 billion in 2025 to $22.2 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.9%. The growth observed in the preceding period can be attributed to the increasing prevalence of refractive vision disorders, rising demand for surgical vision correction, ongoing technological advancements in ophthalmic implants, the growing acceptance of icl procedures, and the expansion of specialized ophthalmic clinics.

The implantable collamer lens market is projected to experience robust expansion in the upcoming years. This market is set to reach $28.74 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.7%. Key factors contributing to this growth during the forecast period include the increasing uptake of high-end vision correction methods, a heightened emphasis on less invasive ophthalmic surgical techniques, the broadening scope of optional eye care services, increased funding for sophisticated ophthalmology technologies, and greater patient understanding of the advantages of ICL. Prominent trends anticipated within this period involve the greater acceptance of EVO implantable collamer lenses, the increased application of laser-guided implantation methods, a surging preference for reversible vision correction, the proliferation of personalized lens options, and a reinforced commitment to sustained visual clarity.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20840&type=smp

Which Drivers Are Supporting The Rise Of The Implantable Collamer Lens Market?

The increasing incidence of vision problems is anticipated to propel the implantable collamer lens market in the future. These disorders encompass conditions impairing clear sight, marked by a progressive reduction in visual sharpness and overall ocular well-being. A global surge in vision disorders is observed, attributed to elements such as an aging demographic, extended periods of screen use, and the growing occurrence of conditions like nearsightedness and age-related macular degeneration. Implantable Collamer Lenses (ICLs) offer an efficacious remedy for rectifying visual impairments including myopia, hyperopia, and astigmatism, presenting a secure, reversible choice compared to conventional refractive procedures such as LASIK. As an illustration, in August 2023, a report from the World Health Organization, a Switzerland-based specialized body of the United Nations, indicated that more than 2.2 billion individuals worldwide experience near or distance vision impairment, and 1 billion of these instances could have been prevented or remain untreated. Consequently, the expanding occurrence of vision challenges is fostering the expansion of the implantable collamer lens market.

What Segments Are Identified Within The Structure Of The Implantable Collamer Lens Market?

The implantable collamer lens market covered in this report is segmented –

1) By Type: Visian Implantable Collamer Lens (ICL), EVO Implantable Collamer Lens (ICL)

2) By Technology Adoption: Laser-Assisted Techniques, Traditional Techniques

3) By Application: Myopia, Hyperopia, Astigmatism

4) By End User: Ophthalmic Clinics, Hospitals, Ambulatory Surgical Center, Other End User

Subsegments:

1) By Visian Implantable Collamer Lens (ICL): Visian ICL for Myopia, Visian ICL For Hyperopia, Visian ICL For Astigmatism, Visian ICL For Presbyopia

2) By EVO Implantable Collamer Lens (ICL): EVO ICL For Myopia, EVO ICL For Hyperopia, EVO ICL For Astigmatism, EVO ICL For Presbyopia

What Upcoming Trends Are Likely To Define The Future Path Of The Implantable Collamer Lens Market?

Leading companies within the implantable collamer lens market are concentrating on technological advancements, such as biocompatible, minimally invasive lens implants designed to correct a broad spectrum of refractive errors without the need to remove corneal tissue, thereby aiming to enhance patient outcomes and lessen reliance on glasses and contact lenses. Biocompatible Minimally Invasive Implantable Lenses provide safe, reversible vision correction by interacting with the natural anatomy of the eye, facilitating quick procedures and resulting in high patient satisfaction. For example, in March 2024, STAAR Surgical Company, an ophthalmic medical device company based in the U.S., announced that over three million EVO ICL lenses have been implanted worldwide. The EVO ICL corrects myopia, with or without astigmatism, and presbyopia, through a 20–30 minute procedure where the lens is positioned between the iris and the eye’s natural crystalline lens. This biocompatible, removable lens presents a cutting-edge alternative to glasses and contacts, assisting millions of patients in achieving improved vision safely and effectively.

Which Major Industry Participants Are Leading The Implantable Collamer Lens Market Growth?

Major companies operating in the implantable collamer lens market are STAAR Surgical Company, Care Group Sight Solutions (IPCL), Ophtec (Artisan Phakic IOLs), Rayner Surgical, Hoya Surgical Optics, Alcon Inc., Johnson & Johnson Vision/Abbott Medical Optics, Bausch + Lomb, Carl Zeiss Meditec AG, Nidek Co. Ltd., Lenstec Inc., SIFI S.p.A., Optimedical, Eyeonics (now part of Santen)*, Physiol LLC, Microlens Tech Co. Ltd., HumanOptics AG, Ocular Instruments Inc., Aaren Scientific LLC, Visiogen Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/implantable-collamer-lens-global-market-report

Which Region Is Projected To Lead The Implantable Collamer Lens Market During The Forecast Period?

North America was the largest region in the implantable collamer lens market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the implantable collamer lens market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Implantable Collamer Lens Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20840&type=smp

Browse Through More Reports Similar to the Global Implantable Collamer Lens Market 2026, By The Business Research Company

Corneal Implants Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/corneal-implants-global-market-report

Prescription Lens Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/prescription-lens-global-market-report

Cataract Surgery Devices And Equipment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/cataract-surgery-devices-and-equipment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company